Trial Site Detail

 

Drug:
DCC-3116 + Ripretinib
Trial:
A Study of DCC-3116 in Combination With Anticancer Therapies in Participants With Advanced Malignancies
Conditions: Gastrointestinal Stromal Tumor
Trial Status:
Recruiting

 

START Midwest Michigan, PC

     
Grand Rapids , MI 49546
USA

 

Principal Investigator:
 Sreenivasa Chandana, MD, PhD
Contact:
 Julie Burns 616-954-5559 julie.burns@startmidwest.com
Activation Status of this Site:
 Active
Notes about this Site:
START Midwest Michigan, PC Website:

 

 

Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.